Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 145 of the 147 references it cites were found in a registry or an index; 45 of the 103 sources its claims cite were checked for support.

2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery

Open access

Abstract

Major updates to 1991 National Institutes of Health guidelines for bariatric surgery Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) > 35 kg/m 2 , regardless of presence, absence, or severity of co-morbidities. MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m 2 . BMI thresholds should be adjusted in the Asian population such that a BMI > 25 kg/m 2 suggests clinical obesity, and individuals with BMI > 27.5 kg/m 2 should be offered MBS. Long-term results of MBS consistently demonstrate safety and efficacy. Appropriately selected children and adolescents should be considered for MBS. (Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013 ) © 2022 American Society for Metabolic and Bariatric Surgery. All rights reserved.

Overview

CoChat Summary

TL;DR

This 2022 ASMBS/IFSO joint statement updates indications for metabolic and bariatric surgery (MBS), recommending MBS for BMI >35 kg/m² regardless of co-morbidities and considering it for BMI 30–34.9 kg/m² with metabolic disease after failed nonsurgical therapy. It also adjusts BMI thresholds for Asian populations, supports carefully selected children/adolescents, and summarizes evidence for safety, efficacy, and durability.

Key findings

  • MBS is recommended for individuals with BMI >35 kg/m² regardless of presence, absence, or severity of co-morbidities; it should be considered for BMI 30–34.9 kg/m² with metabolic disease, especially type 2 diabetes, when nonsurgical methods fail.
  • In Asian populations, clinical obesity is recognized at BMI >25 kg/m², and MBS should be offered at BMI >27.5 kg/m²; access should not be denied solely by traditional BMI thresholds.
  • Pediatric/adolescent MBS should be considered for BMI >120% of the 95th percentile with a major co-morbidity, or BMI >140% of the 95th percentile, after multidisciplinary evaluation.
  • Reported benefits include perioperative mortality of 0.03–0.2%, durable weight loss generally >60% excess weight loss, cancer risk reduction of 11–50% for all cancer types, 32% lower cancer risk and 48% lower cancer-related death in a >30,000-patient cohort, and mortality reductions such as 30.7% in the Swedish Obese Subjects study and 40% after RYGB in another cohort.

Methods

  • Design: joint ASMBS/IFSO consensus statement and clinical guideline updating the 1991 NIH Consensus Statement on gastrointestinal surgery for severe obesity.
  • Data/sample: narrative synthesis of published literature, prior society statements, and expert consensus; no primary patient sample, systematic search, or meta-analysis is described.
  • Main analysis: expert interpretation of evidence on BMI thresholds, age extremes, high-risk patients, bridge-to-transplant/surgery indications, outcomes, and revisional surgery to produce recommendations.

Limitations

  • The paper states that BMI has limitations for accurately risk-stratifying patients with obesity, that there is a paucity of data on surgical outcomes in patients with clinically significant portal hypertension, and that there is no consensus on the best procedure for individuals with especially high BMI.
  • The paper notes that evidence for cancer risk reduction may attenuate over time and that confounding by operation type, cancer type, health behaviors, and co-morbidities is unclear.
  • Evident from the text: this is a consensus/narrative guideline rather than a systematic review, and no formal search strategy, evidence grading, or quantitative synthesis is reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s11695-022-06332-1

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

20 Valid · 0 Not valid · 25 Not checked · 6 Own results and interpretations

24 more claims · 6 with their cited sources checked

Create a free account to see all 51 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 22

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 147 references

Research works printed but not linked: 1

  1. Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54. · DOI · Paper page

Cited by

See all 768

Metadata

Authors
Eisenberg, D., Shikora, S. A., Aarts, E., Aminian, A., Angrisani, L., Cohen, R. V., de Luca, M., Faria, S. L., Goodpaster, K. P. S., Haddad, A., Himpens, J. M., Kow, L., Kurian, M., Loi, K., Mahawar, K., Nimeri, A., O’Kane, M., Papasavas, P. K., Ponce, J., Pratt, J. S. A., Rogers, A. M., Steele, K. E., Suter, M., & Kothari, S. N.
Affiliations
  • VA Palo Alto Health Care System (US)
  • Brigham and Women's Hospital (US)
  • Cleveland Clinic (US)
  • University of Naples Federico II (IT)
  • Hospital Alemão Oswaldo Cruz (BR)
  • Jordan Hospital (JO)
  • Centre Hospitalier Interrégional Edith Cavell (BE)
  • Flinders University (AU)
  • New York University (US)
  • Sutherland Hospital (AU)
  • Sunderland Royal Hospital (GB)
  • University of North Carolina at Charlotte (US)
  • Leeds Teaching Hospitals NHS Trust (GB)
  • Hartford Hospital (US)
  • CHI Memorial Medical Group (US)
  • Lucile Packard Children's Hospital (US)
  • Penn State Milton S. Hershey Medical Center (US)
  • National Institutes of Health (US)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • Prisma Health (US)
Corresponding author
Eisenberg, Dan
Venue
Obesity Surgery
Published
2022-11-07
Volume
33
Issue
1
Pages
3-14
ISSN
  • 0960-8923 (ISSN-L)
  • 1708-0428
OpenAlex
W4308295896
Cited by
768
References
147
Citations by year
2026: 214 · 2025: 233 · 2024: 211 · 2023: 104 · 2022: 4
FWCI
117.54
Type
journal article
Language
en
Open access
Licence
Locations
  • Obesity Surgery (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion, cc-by)
  • SERVAL (Université de Lausanne) (submittedVersion, cc-by)
  • Greater South Information System
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Surgery › Body Contouring and Surgery
  • Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
Keywords
bariatric surgery, surgical indications
MeSH terms
Adolescent, Child, Humans, Metabolic Diseases, Obesity, Obesity, Morbid, United States, Body Mass Index, Bariatric Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. https://app.cochat.ai/papers/10.1007/s11695-022-06332-1
The paper
Eisenberg, D., Shikora, S. A., Aarts, E., Aminian, A., Angrisani, L., Cohen, R. V., de Luca, M., Faria, S. L., Goodpaster, K. P. S., Haddad, A., Himpens, J. M., Kow, L., Kurian, M., Loi, K., Mahawar, K., Nimeri, A., O’Kane, M., Papasavas, P. K., Ponce, J., . . . Kothari, S. N. (2023). 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. Obesity Surgery. https://doi.org/10.1007/s11695-022-06332-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.